134 related articles for article (PubMed ID: 34339089)
1. Quality of care in people requiring hospital admission for gout in Aotearoa New Zealand: a nationwide analysis.
Murdoch R; Jones P; Greenwell J; Dalbeth N
Intern Med J; 2022 Dec; 52(12):2136-2142. PubMed ID: 34339089
[TBL] [Abstract][Full Text] [Related]
2. Variation in gout care in Aotearoa New Zealand: a national analysis of quality markers.
Jackson G; Dalbeth N; Te Karu L; Winnard D; Gow P; Gerard C; Minko N
N Z Med J; 2014 Oct; 127(1404):37-47. PubMed ID: 25331310
[TBL] [Abstract][Full Text] [Related]
3. Potential unmet need for gout diagnosis and treatment: capture-recapture analysis of a national administrative dataset.
Jackson G; Wright C; Thornley S; Taylor WJ; Te Karu L; Gow PJ; Arroll B; Gribben B; Dalbeth N; Winnard D
Rheumatology (Oxford); 2012 Oct; 51(10):1820-4. PubMed ID: 22723595
[TBL] [Abstract][Full Text] [Related]
4. National prevalence of gout derived from administrative health data in Aotearoa New Zealand.
Winnard D; Wright C; Taylor WJ; Jackson G; Te Karu L; Gow PJ; Arroll B; Thornley S; Gribben B; Dalbeth N
Rheumatology (Oxford); 2012 May; 51(5):901-9. PubMed ID: 22253023
[TBL] [Abstract][Full Text] [Related]
5. Interventions designed to improve uptake of allopurinol for gout treatment in Aotearoa New Zealand: a scoping review.
Ofanoa S; Ofanoa M; Tu'akoi S; Lutui H; Heather M; Jansen RM; Dalbeth N; Grey C; Goodyear-Smith F
J Prim Health Care; 2023 Mar; 15(1):48-58. PubMed ID: 37000552
[TBL] [Abstract][Full Text] [Related]
6. Regular pre-admission urate-lowering therapy and serum urate testing are associated with a shorter hospital length of stay in people with gout: A nation-wide population-based cohort study.
Jatuworapruk K; Grainger R; Dalbeth N; Taylor WJ
Int J Rheum Dis; 2022 Feb; 25(2):154-162. PubMed ID: 34796661
[TBL] [Abstract][Full Text] [Related]
7. Factors associated with recurrent hospital admissions for gout: a case-control study.
Hutton I; Gamble G; Gow P; Dalbeth N
J Clin Rheumatol; 2009 Sep; 15(6):271-4. PubMed ID: 19734730
[TBL] [Abstract][Full Text] [Related]
8. Allopurinol use in a New Zealand population: prevalence and adherence.
Horsburgh S; Norris P; Becket G; Arroll B; Crampton P; Cumming J; Keown S; Herbison P
Rheumatol Int; 2014 Jul; 34(7):963-70. PubMed ID: 24390636
[TBL] [Abstract][Full Text] [Related]
9. Facilitating equitable prevention and management of gout for Māori in Northland, New Zealand, through a collaborative primary care approach.
Lawrence A; Scott S; Saparelli F; Greville G; Miller A; Taylor A; Gow P
J Prim Health Care; 2019 Jul; 11(2):117-127. PubMed ID: 32171354
[TBL] [Abstract][Full Text] [Related]
10. The safety and efficacy of benzbromarone in gout in Aotearoa New Zealand.
Stamp LK; Haslett J; Frampton C; White D; Gardner D; Stebbings S; Taylor G; Grainger R; Kumar R; Kumar S; Kain T; Porter D; Corkill M; Cathro A; Metcalfe S; Wyeth J; Dalbeth N
Intern Med J; 2016 Sep; 46(9):1075-80. PubMed ID: 27391386
[TBL] [Abstract][Full Text] [Related]
11. An Observational Study of Gout Prevalence and Quality of Care in a National Australian General Practice Population.
Robinson PC; Taylor WJ; Dalbeth N
J Rheumatol; 2015 Sep; 42(9):1702-7. PubMed ID: 26233513
[TBL] [Abstract][Full Text] [Related]
12. Design and implementation of a Pacific intervention to increase uptake of urate-lowering therapy for gout: a study protocol.
Ofanoa M; Ofanoa SM; Heather M; Tu'akoi S; Lutui H; Dalbeth N; Grey C; van der Werf B; Goodyear-Smith F
Int J Equity Health; 2021 Dec; 20(1):262. PubMed ID: 34949187
[TBL] [Abstract][Full Text] [Related]
13. Understanding and improving the use of allopurinol in a teaching hospital.
Hmar RC; Kannangara DR; Ramasamy SN; Baysari MT; Williams KM; Day RO
Intern Med J; 2015 Apr; 45(4):383-90. PubMed ID: 25644128
[TBL] [Abstract][Full Text] [Related]
14. Inpatient management of gout in a New Zealand hospital: a retrospective audit.
Kennedy NJ; Healy PJ; Harrison AA
Int J Rheum Dis; 2016 Feb; 19(2):205-10. PubMed ID: 25873399
[TBL] [Abstract][Full Text] [Related]
15. Incorporating gout guideline advice into urate reports is associated with reduced hospital admissions: results of an observational study.
Riches PL; Downie L; Thomson C
Rheumatology (Oxford); 2022 May; 61(5):1885-1891. PubMed ID: 34528071
[TBL] [Abstract][Full Text] [Related]
16. Hospital admissions associated with gout and their comorbidities in New Zealand and England 1999-2009.
Robinson PC; Merriman TR; Herbison P; Highton J
Rheumatology (Oxford); 2013 Jan; 52(1):118-26. PubMed ID: 22989425
[TBL] [Abstract][Full Text] [Related]
17. Gout medication treatment patterns and adherence to standards of care from a managed care perspective.
Sarawate CA; Brewer KK; Yang W; Patel PA; Schumacher HR; Saag KG; Bakst AW
Mayo Clin Proc; 2006 Jul; 81(7):925-34. PubMed ID: 16835972
[TBL] [Abstract][Full Text] [Related]
18. Hospitalizations for Acute Gout: Process Mapping the Inpatient Journey and Identifying Predictors of Admission.
Russell MD; Nagra D; Clarke BD; Balachandran S; Buazon A; Boalch A; Bechman K; Adas MA; Alveyn EG; Rutherford AI; Galloway JB
J Rheumatol; 2022 Jul; 49(7):725-730. PubMed ID: 35293331
[TBL] [Abstract][Full Text] [Related]
19. Utilization of allopurinol in the Australian community.
Chung Y; Lu CY; Graham GG; Mant A; Day RO
Intern Med J; 2008 Jun; 38(6):388-95. PubMed ID: 18422564
[TBL] [Abstract][Full Text] [Related]
20. Association between gout and cardiovascular outcomes in adults with no history of cardiovascular disease: large data linkage study in New Zealand.
Cai K; Wu B; Mehta S; Harwood M; Grey C; Dalbeth N; Wells SM; Jackson R; Poppe K
BMJ Med; 2022; 1(1):e000081. PubMed ID: 36936597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
